Hepatic arterial embolisation with irinotecan versus systemic FOLFIRI in patients with liver metastases from colorectal cancer

Trial Profile

Hepatic arterial embolisation with irinotecan versus systemic FOLFIRI in patients with liver metastases from colorectal cancer

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Jun 2012

At a glance

  • Drugs Irinotecan (Primary) ; Fluorouracil; Folinic acid; Irinotecan
  • Indications Colorectal cancer; Liver metastases
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 21 Jan 2012 Results presented at the 2012 Gastrointestinal Cancers Symposium.
    • 12 Oct 2010 Updated 24-month results (n=74) presented at the 35th Congress of the European Society for Medical Oncology
    • 27 Jun 2009 Interim 18-month primary endpoint results presented at the 11th World Congress on Gastrointestinal Cancer
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top